Cargando…
Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era
We evaluated the clinical significance of prognostic factors including the International Staging System (ISS) and modified European Group for Blood and Marrow Transplantation response criteria in 1650 Japanese patients with multiple myeloma (MM) who underwent upfront single autologous stem cell tran...
Autores principales: | Takamatsu, Hiroyuki, Honda, Sumihisa, Miyamoto, Toshihiro, Yokoyama, Kenji, Hagiwara, Shotaro, Ito, Toshiro, Tomita, Naoto, Iida, Shinsuke, Iwasaki, Toshihiro, Sakamaki, Hisashi, Suzuki, Ritsuro, Sunami, Kazutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399028/ https://www.ncbi.nlm.nih.gov/pubmed/25530023 http://dx.doi.org/10.1111/cas.12594 |
Ejemplares similares
-
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
por: Takamatsu, Hiroyuki, et al.
Publicado: (2023) -
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR
por: Takezako, Naoki, et al.
Publicado: (2020) -
A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial
por: Ichinohe, Tatsuo, et al.
Publicado: (2016) -
Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma
por: Matsue, Kosei, et al.
Publicado: (2015) -
Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine
por: Fragoso, Alberto, et al.
Publicado: (2020)